Netflix: What Next?
When you find the thing you never knew you needed, it can bring everyone together.
Multiple class-action lawsuits regarding the marketing of GLP-1 RAs were transferred to be heard together as part of multidistrict litigation (MDL). More information on the MDL is below.
In Re: Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation
24-md-3094, E.D. Penn.
(2024)
Ozempic, Wegovy, Rybelsus, Saxenda, Victoza, Mounjaro, Zepbound, Trulicity and other GLP-1 RA medications
Marketing products as weight-loss medications without adequately disclosing that many people stop using them due to their side effects, the medications do not result in meaningful weight loss for up to 15 percent of people, the average weight loss is approximately 10 percent of a person’s body weight, and people need to stay on them to maintain their weight loss
Pending
When you find the thing you never knew you needed, it can bring everyone together.
Purported closing-down sale is deceiving consumers, with the help of AI.
Company hits snooze on promised marketing changes.
Matt Gephardt, KSL.com
Is this drink’s packaging whispering sweet nothings?